Category Archives: Conferences

At IDWeek 2025, held in Atlanta, Georgia, USA, from October 19-22, 2025, Dr. Nguyen Hoa Anh representing LiveSpo Pharma and Assoc. Prof. Dr. Nguyen Thi Van Anh representing the Spobiotic Research Center – ANABIO R&D, presented new research findings on the effectiveness of nasal-spray Bacillus spores in preventing respiratory infections in children. This study is part of a collaborative effort among the Institute for Preventive Medicine and Public Health – Hanoi Medical University, Hanoi University of Public Health, and several other research institutions.

The conference brought together more than 10,000 physicians and scientists from over 100 countries and is recognized as one of the world’s leading forums in infectious diseases and antimicrobial resistance. IDWeek features a wide range of cutting-edge scientific updates through plenary sessions, keynote lectures, pre-meeting workshops, symposia, oral presentations, and poster sessions across specialized tracks such as antimicrobial resistance and stewardship, HIV, pediatric infectious diseases, public health, respiratory, gastrointestinal, urinary and sexually transmitted infections, epidemiology, and community healthcare.

The team’s poster booth attracted strong interest from many infectious disease physicians, hospital-based laboratory researchers, and R&D specialists from numerous countries, including the United States, the United Kingdom, Switzerland, France, Sweden, Spain, Colombia, Canada, Japan, Brazil, China, India, and Tanzania.

Throughout the exhibition, the team engaged in scientific discussions with visitors on topics related to LiveSpo Navax-the nasal-spray Bacillus spore probiotic for preventing and supporting the treatment of respiratory infections. Key discussion themes included product composition and mechanisms of action, modulation of the nasal microbiome, and its role in preventing and alleviating respiratory infections.

Many scientists expressed particular interest in the concept of a “nasal-spray probiotic,” viewing it as an innovative direction in microbial technology for respiratory health protection. They highly appreciated the product’s safety profile-showing no mucosal irritation and no adverse effects reported during clinical trials. Several researchers were especially intrigued by the adhesion and activity of Bacillus spores on the nasal mucosa, their potential to protect against multiple respiratory viruses, and the prospect of expanding research into other population groups beyond children.

Participating in IDWeek 2025 provided an important opportunity for ANABIO R&D’s Spobiotic Research Center to present Vietnam’s scientific achievements to the international community, while expanding collaborations in probiotics and in the biological, safe control of infectious diseases.

From June 9-13, 2022, the 2022 International Microbiology Conference took place in Washington DC. The conference is organized by the American Society for Microbiology Microbe (ASM Microbe 2022), which is the largest and most prestigious organization in the field of microbiology in the world.

The conference is a forum for scientists around the world to exchange discoveries, creativity and research collaboration in different fields of microbiology.

Participating in the Conference, there were many useful and quality scientific reports from research organizations from all over the world, including the participation of researchers from the Center for Cell Research. Probiotic bacteria, ANABIO R&D Co., Ltd.

At the Conference, Dr. Nguyen Hoa Anh and CN. Bui Thi Huyen – ANABIO R&D has had 03 reports related to the clinical trial results of the probiotic product LiveSpo Navax conducted at the National Children’s Hospital.

LiveSpo Navax, containing 5 billion spores of the beneficial bacteria Bacillus subtilis and Bacillus clausii in nasal spray form, has a significant effect in shortening the duration of treatment of respiratory infections in children infected with respiratory syncytial virus (RSV) and flu. Research shows that LiveSpo NAVAX reduces the concentration of these two viruses about 50-60 times more effectively than physiological saline. Besides, LiveSpo NAVAX also works to reduce “cytokine storm” clearly, has anti-inflammatory and nasal congestion effect.

Regarding beneficial bacteria for gastrointestinal diseases, ANABIO R&D also had 01 report on heat stability, acid stability, time stability and safety of LiveSpo Clausy product, which has a significant supportive effect in reducing tangles. Digestive disorders when taking antibiotics.

Research shows that LiveSpo Clausy is very safe, has stable quality during storage, does not reduce its effect when it passes through the stomach, when it enters the intestines, it promotes the effect of improving the intestinal microflora, bringing the intestinal microflora to the balance ratio of 80:20 between good bacteria and bad bacteria after only 28 days of use.

The conference ended successfully after 5 days, leaving many good impressions for the scientists who attended the conference about the professionalism in the organization and the scientific quality of the reports. Through the conference, ANABIO R&D was highly appreciated by the scientific community for its product quality as well as contributing to improving the reputation of Vietnamese brands in the field of probiotics in the world.